IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v41y2018i9d10.1007_s40264-018-0673-z.html
   My bibliography  Save this article

Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial

Author

Listed:
  • Nigel S. B. Rawson

    (Eastlake Research Group
    Canadian Health Policy Institute
    Fraser Institute)

  • Carl D’Arcy

    (University of Saskatchewan)

Abstract

Administrative healthcare utilization databases are frequently used either individually or as a component of aggregated data for evaluating drug safety issues without taking into account their known deficiencies. All too often insufficient evidence is provided about their validity for the purposes for which they are used. The assessment of data validity is a key constituent that should be included in drug safety research studies and should take a broad multifaceted approach that encompasses both diagnostic and drug exposure data. Drug safety researchers need to continue advancing their knowledge of the data resources they use and to ensure that they and the users of their research understand the limitations of the data that are the foundation on which their research is built. Fundamental issues regarding data validity should be addressed in each use of administrative data for drug safety research.

Suggested Citation

  • Nigel S. B. Rawson & Carl D’Arcy, 2018. "Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial," Drug Safety, Springer, vol. 41(9), pages 829-833, September.
    • Handle: RePEc:spr:drugsa:v:41:y:2018:i:9:d:10.1007_s40264-018-0673-z
    DOI: 10.1007/s40264-018-0673-z
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-018-0673-z
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-018-0673-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:41:y:2018:i:9:d:10.1007_s40264-018-0673-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.